Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Por um escritor misterioso
Descrição
Discovery of M-1121 as an Orally Active Covalent Inhibitor of
Therapeutic implications of menin inhibition in acute leukemias
Synergistic targeting of FLT3 mutations in AML via combined menin
Molecules, Free Full-Text
Co-inhibition of HDAC and MLL-menin interaction targets MLL
Molecular switch between mammalian MLL complexes dictates response
Challenges and opportunities in targeting the menin-MLL
MI-2-2 exhibits pronounced activity in MV4;11 human leukemia cells
A molecular switch between mammalian MLL complexes dictates
Theoretical models of inhibitory activity for inhibitors of
Menin-MLL inhibitors block oncogenic transformation by MLL-fusion
RCSB PDB - 4GQ6: Human menin in complex with MLL peptide
Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction
Frontiers MLL-Rearranged Leukemias—An Update on Science and
Challenges and opportunities in targeting the menin–MLL
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/cdn.vox-cdn.com/uploads/chorus_image/image/69131250/Tanjiro__Demon_Slayer_.0.png)
